EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A multivariate retrospective analysis of high‐grade gliomas: Survival and prognostic factors

Weiyan Shi iD, Xuanzhong Wang, Shiyu Liu, Zhuangzhuang Zheng, Lihua Dong, Xin Jiang iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.7456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Weiyan Shi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Jilin Provincial Key Laboratory of Radiation Oncology & Therapy, The First Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Neoplasm Grading. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Provincial Science and Technology Foundations.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

High‐grade gliomas (HGGs) are highly malignant, aggressive, and have a high incidence and mortality rate. The aim of this study was to investigate survival outcomes and prognostic factors in patients with HGGs.

Methods

In this retrospective study, a total of 159 patients with histologically confirmed HGGs were included. The recruitment period was from January 2011 to December 2019. We evaluated patient demographic data, tumor characteristics, treatment methods, immunocytochemistry results, overall survival (OS) time, and progression‐free survival (PFS) time using Kaplan–Meier survival analysis with log‐rank testing. Additionally, we employed Cox regression analysis to identify independent factors associated with survival outcomes.

Results

Kaplan–Meier survival analysis revealed that the 1‐, 2‐, and 5‐years OS rates were 81.8%, 50.3%, and 12.6%, respectively. Similarly, the 1‐, 2‐, and 5‐years PFS rates were 50.9%, 22.4%, and 3.1%, respectively. The median OS duration was 35.0 months. The univariate analysis indicated that postoperative pathological classification, grade, and age were significantly associated with patient outcomes ( p < 0.01). Among the patients, 147 received concurrent chemoradiotherapy, while 12 did not. The immunohistochemical markers of ki‐67, MGMT, IDH1R132H, and p53 demonstrated statistically significant differences in their prognostic impact ( p = 0.001, p = 0.020, p = 0.003, and p = 0.021, respectively). In conclusion, we found that grades, age, pathological classification, ki‐67, MGMT, and IDH1R132H expression were statistically significantly associated with PFS ( p < 0.01, p = 0.004, p = 0.003, p = 0.001, p = 0.036, and p = 0.028). Additionally, immunohistochemical expressions of TRIB3 and AURKA were significantly higher in patients with shorter survival ( p = 0.015 and p = 0.023).

Conclusions

Tumor grade and the use of concurrent chemoradiotherapy after surgery were independent prognostic factors that significantly influenced patient survival. Additionally, tumor grade and MGMT expression were found to be independent factors affecting progression‐free survival (PFS). Notably, the expression of TRIB3 and AURKA was higher in patients with poor survival outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaBrain NeoplasmsNeoplasm GradingHumansFemaleMaleRetrospective StudiesMiddle AgedAdultPrognosisAgedChemoradiotherapyYoung AdultKaplan-Meier EstimateBiomarkers, TumorProgression-Free SurvivalIsocitrate DehydrogenaseDNA Modification MethylasesMultivariate AnalysisTumor Suppressor ProteinsSurvival RateAdolescentDNA Repair Enzymes

Stichwörter der Autor:innen

Trib3high‐grade gliomasimmunohistochemicaloverall survivalprogression‐free survival

Substanzen

Biomarkers, TumorIsocitrate DehydrogenaseDNA Modification MethylasesTumor Suppressor ProteinsMGMT protein, humanDNA Repair Enzymes

Autor:innen und Institutionen

  • Jilin Provincial Key Laboratory of Radiation Oncology & Therapy, The First Hospital of Jilin University, Changchun, China.
  • Department of Radiation Oncology, The First Hospital of Jilin University, Changchun, China.
  • NHC Key Laboratory of Radiobiology, School of Public Health, Jilin University, Changchun, China.

ORCID-Profile: Weiyan Shi, Xin Jiang

Förderung

  • Jilin Provincial Science and Technology Foundations

Zitieren

APA

Shi, W., Wang, X., Liu, S., Zheng, Z., Dong, L., & Jiang, X. (2024). A multivariate retrospective analysis of high‐grade gliomas: Survival and prognostic factors. Cancer Medicine. https://doi.org/10.1002/cam4.7456

Vancouver

Shi W, Wang X, Liu S, Zheng Z, Dong L, Jiang X. A multivariate retrospective analysis of high‐grade gliomas: Survival and prognostic factors. Cancer Medicine. 2024. doi:10.1002/cam4.7456

BibTeX
@article{Shi2024,
  author = {Shi, Weiyan and Wang, Xuanzhong and Liu, Shiyu and Zheng, Zhuangzhuang and Dong, Lihua and Jiang, Xin},
  title = {A multivariate retrospective analysis of high‐grade gliomas: Survival and prognostic factors},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.7456}
}
Kostenlos starten →